Pauwels RWM, Proietti E, van der Woude CJ, Oudijk L, et al. Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021 Mar 11. pii: 6168345. doi: 10.1093.
PMID: 33705545